ArticleJournal of pharmaceutical and biomedical analysis2026
Corrigendum to "Characterizing the metabolites of the tyrosine-kinase inhibitor pexidartinib in mouse feces, urine, plasma, and liver" [J. Pharm. Biomed. Anal. 265 (2025) 117034].
Xuan Qin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.